Kim Robert Young has filed 11 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 92300 shares of 4D Molecular Therapeutics, Inc. ($FDMT) on March 06, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2025 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | A | Stock Option (Right to Buy) | 92300 | $0.00 | 92,300.0000 | 46,302,407 | 9999.99% | 0.20% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Common Stock | 12000 | $18.66 | 13,595.0000 | 0 | 752.35% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | S | Common Stock | 12000 | $30.05 | 1,595.0000 | 0 | 88.27% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Common Stock | 6000 | $15.78 | 7,595.0000 | 0 | 376.18% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | S | Common Stock | 6000 | $30.05 | 1,595.0000 | 0 | 79.00% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Common Stock | 6000 | $8.04 | 7,595.0000 | 0 | 376.18% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | S | Common Stock | 6000 | $30.05 | 1,595.0000 | 0 | 79.00% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | S | Common Stock | 552 | $30.05 | 1,043.0000 | 0 | 34.61% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Stock Option (Right to Buy) | 12000 | $0.00 | 138,000.0000 | 0 | 8.00% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Stock Option (Right to Buy) | 6000 | $0.00 | 64,000.0000 | 0 | 8.57% | 0.00% |
| Feb. 5, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | Kim Robert Young | Chief Medical Officer | M | Stock Option (Right to Buy) | 6000 | $0.00 | 54,000.0000 | 0 | 10.00% | 0.00% |